Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Open-Angle Glaucoma (OAG) Market By 2029?
The open-angle glaucoma (oag) market size has experienced significant expansion in recent years. It is projected to increase from $6.13 billion in 2024 to $6.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.5%. The growth observed in the past can be linked to the increasing occurrence of glaucoma among older demographics, heightened awareness regarding the early detection of eye conditions, rising expenditure on healthcare, government programs for vision care, and the worldwide proliferation of ophthalmology practices.
The market for open-angle glaucoma (oag) is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $8.36 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. The predicted growth during this period can be attributed to several factors, including a growing demand for combination therapies, an increasing emphasis on personalized medicine, enhanced reimbursement policies for glaucoma treatments, a rising occurrence of lifestyle-induced ocular conditions, and an escalating need for non-invasive diagnostic approaches. Key trends identified for the forecast timeframe encompass the expanding adoption of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical interventions, the greater utilization of sustained-release glaucoma implants, increasing incorporation of wearable technology for monitoring intraocular pressure, and an intensified focus on sustainability within medical device production.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What Are The Top Growth Drivers Impacting The Open-Angle Glaucoma (OAG) Market Outlook?
The increasing recognition of eye conditions is set to stimulate the expansion of the open-angle glaucoma (OAG) market. Eye illnesses encompass medical conditions affecting the structure, function, or vision of the eyes, ranging from minor issues like dry eye to serious diseases such as glaucoma and macular degeneration. Their prevalence is on the rise due to factors including aging populations, extended screen time, a surge in diabetes cases, environmental pollution, and lifestyle habits that compromise eye health. Open-angle glaucoma (OAG), a leading cause of blindness, particularly among older adults, emphasizes the crucial need for routine eye exams, early diagnosis, and proactive treatment to protect against irreversible vision loss. For instance, in October 2023, the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, reported that eye care outpatient appointments in the UK exceeded eight million in 2021/22, making it the most demanded specialty. Moreover, the number of individuals with sight loss, currently surpassing two million, is projected to double to over four million by 2050. Thus, the growing awareness of eye illnesses is driving growth in the open-angle glaucoma (OAG) market.
Which Key Segments Fueling The Open-Angle Glaucoma (OAG) Market?
The open-angle glaucoma (oag)market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type
2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma
What Are The Latest Industry Trends Transforming The Open-Angle Glaucoma (OAG) Market?
Leading companies in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less intrusive options for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a variety of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.
Which Key Players Are Driving Competition In The Open-Angle Glaucoma (OAG) Market?
Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Which Region Currently Holds The Largest Share Of The Open-Angle Glaucoma (OAG) Market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Open-Angle Glaucoma (OAG) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp
Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2025, By The Business Research Company
Antiglaucoma Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report
Glaucoma Surgery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report
Myopia And Presbyopia Treatment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model